Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment [Polysporin] — RxCUI 213626
RxNorm drug concept · Semantic branded drug
RxCUI 213626
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI213626
Official nameBacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment [Polysporin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPolysporin (bacitracin 0.5 UNT / polymyxin B 10 UNT) per MG Topical Ointment; Polysporin 500 UNT / 10,000 UNT per GM Topical Ointment; Polysporin (bacitracin 500 UNT / polymyxin B 10,000 UNT) per GM Topical Ointment
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bacitracin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is first aid to help prevent infection in minor cuts, scrapes, and burns. One cream product also has directions for athlete's foot, ringworm and jock itch.
- Clean the area, then put on a small amount, about the size of your fingertip. Do this 1 to 3 times a day, and you can cover it with a sterile bandage. One cream product is used as...
- Not longer than 1 week unless a doctor tells you to. If the problem is not getting better or gets worse, stop and check with a doctor.
- Stop if you get a rash or any allergic reaction, and talk to a doctor. Don't use it if you are allergic to any ingredient.
🕸️ Concept Web — How Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG To... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment [Polysporin]
RxCUI 213626 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Bacitracin
1291IN -
Polymyxin B
8536IN -
Bacitracin / polymyxin B
645555MIN
-
Bacitracin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Polysporin
54955BN
-
Polysporin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bacitracin / polymyxin B Topical Ointment
374631SCDF -
Bacitracin / polymyxin B Topical Product
1155354SCDG -
Bacitracin / polymyxin B Topical Ointment [Polysporin]
93814SBDF -
Polysporin Topical Product
1183534SBDG -
Topical Ointment
316985DF -
Topical Product
1151122DFG
-
Bacitracin / polymyxin B Topical Ointment
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment
308512SCD -
Bacitracin 0.5 UNT/MG
315454SCDC -
Polymyxin B 10 UNT/MG
328475SCDC -
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG [Polysporin]
572461SBDC
-
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment
Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment
SCD · 308512 -
Bacitracin 0.5 UNT/MG
SCDC · 315454 -
Polymyxin B 10 UNT/MG
SCDC · 328475 -
Bacitracin / polymyxin B Topical Ointment
SCDF · 374631 -
Bacitracin / polymyxin B Topical Product
SCDG · 1155354
Brand-Name Concepts
-
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG [Polysporin]
SBDC · 572461 -
Bacitracin / polymyxin B Topical Ointment [Polysporin]
SBDF · 93814 -
Polysporin Topical Product
SBDG · 1183534 -
Polysporin
BN · 54955
📦 FDA Products & Package NDCs
1 product · 4 package NDCs
4 package NDCs map to RxCUI 213626 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69968-0060-01 | .9 g in 1 PACKET (69968-0060-1) | Polysporin First Aid Antibiotic | Kenvue Brands LLC | 2013-07-09 |
| 69968-0060-02 | 1 TUBE in 1 CARTON (69968-0060-2) / 28.3 g in 1 TUBE | Polysporin First Aid Antibiotic | Kenvue Brands LLC | 2013-07-09 |
| 69968-0060-03 | 1 TUBE in 1 CARTON (69968-0060-3) / 14.2 g in 1 TUBE | Polysporin First Aid Antibiotic | Kenvue Brands LLC | 2013-07-09 |
| 69968-0060-09 | 144 PACKET in 1 CARTON (69968-0060-9) / .9 g in 1 PACKET | Polysporin First Aid Antibiotic | Kenvue Brands LLC | 2013-07-09 |
Observed labelers:
Kenvue Brands LLC (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.